Misconceptions about hidradenitis suppurativa (HS) prevent dermatologists and other clinicians from properly diagnosing and treating what one expert says is a “crippling disease.”
One of the misunderstandings about HS is that it’s rare, according to, professor and chair of dermatology at Roskilde Hospital, Health Sciences Faculty, University of Copenhagen, Denmark, who chaired a section on hidradenitis suppurativa at the 2015 World Congress of Dermatology in Vancouver, Canada.
“U.S. registry studies suggest [it is rare], while European population studies suggest it is not,” Dr. Jemec says. “It is like looking in hospital records for how many people suffer from the common cold in November. You are not likely to get the impression that it is particularly common.”
HS prevalence in the Europe, including mild cases, is reported to be between 1 and 2 percent, according to Dr. Jemec. And most HS patients are young adults.Case Study Dermatology Diagnosis Pathology Specialist Treatment